ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Catalyst holds firm on $300,000-plus net for Firdapse despite Bernie Sanders’ demands to justify the price fiercepharma
February 24, 2019Just one week after Vermont?Sen. Bernie Sanders?sent a scathing letter to Catalyst Pharmaceuticals CEO questioning his plans to charge $375,000 for its rare-disease drug Firdapse, the company said it's sticking to that number. -
Catalyst holds firm on $300,000-plus net for Firdapse despite Bernie Sanders’ demands to justify the price fiercepharma
February 24, 2019Just one week after Vermont?Sen. Bernie Sanders?sent a scathing letter to Catalyst Pharmaceuticals CEO questioning his plans to charge $375,000 for its rare-disease drug Firdapse, the company said it's sticking to that number.
Pharma Sources Insight January 2025
